Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer

Historically, the clinical utility of oncolytic virotherapy as a treatment for a wide range of cancer types was first demonstrated by three pilot human clinical trials conducted in Japan in the 1970s and 1980s using a wild-type Urabe mumps virus (MuV) clinical isolate. Using a sample of the actual o...

Descripción completa

Detalles Bibliográficos
Autores principales: Behrens, Marshall D., Stiles, Robert J., Pike, Gennett M., Sikkink, Laura A., Zhuang, Yongxian, Yu, Jia, Wang, Liewei, Boughey, Judy C., Goetz, Matthew P., Federspiel, Mark J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703006/
https://www.ncbi.nlm.nih.gov/pubmed/36458203
http://dx.doi.org/10.1016/j.omto.2022.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703006/
https://www.ncbi.nlm.nih.gov/pubmed/36458203
http://dx.doi.org/10.1016/j.omto.2022.11.002

Ejemplares similares